Next 10 |
2024-10-03 08:40:25 ET More on Aldeyra Therapeutics Aldeyra Therapeutics Has Data To Trigger AbbVie Partnership Aldeyra climbs after late-stage success for dry eye disease therapy Seeking Alpha’s Quant Rating on Aldeyra Therapeutics Historical earnings...
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the resubmission of a New Drug Application (NDA) to the U.S. Food and Drug Administra...
Aldeyra Therapeutics Inc. (ALDX) is expected to report $-0.21 for Q2 2024 Cano Health Inc. Class A (CANOQ) is expected to report for Q2 2024 Aytu BioPharma Inc. (AYTU) is expected to report for quarter end 2024-06-30 BlackBerry Limited (BB) is expected to report $-0.04 for Q2 2025 ...
Aldeyra Therapeutics Inc. (ALDX) is expected to report $-0.21 for Q2 2024 FactSet Research Systems Inc. (FDS) is expected to report $3.6 for Q4 2024 China CITIC Bank Corp. Ltd. ADR (CHCJY) is expected to report for Q2 2024 Comera Life Sciences Holdings Inc. (CMRA) is expected to repor...
2024-09-15 19:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Comera Life Sciences Holdings Inc. (CMRA) is expected to report for quarter end 2024-06-30 China CITIC Bank Corp. Ltd. ADR (CHCJY) is expected to report for Q2 2024 Big Lots Inc. (BIGGQ) is expected to report $-3.71 for Q2 2025 Cano Health Inc. Class A (CANOQ) is expected to report fo...
Delta Apparel Inc. (DLAPQ) is expected to report for Q3 2024 Citrine Global Corp (CTGL) is expected to report for quarter end 2024-06-30 American Outdoor Brands Inc. (AOUT) is expected to report $-0.09 for Q1 2025 CURO Group Holdings Corp. (CUROQ) is expected to report for Q2 2024 ...
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will particip...
2024-08-30 12:30:49 ET Summary The 'Undercovered' Dozen series highlights 12 lesser-known stocks, offering fresh investment ideas and encouraging community discussion on their potential. Kraken Robotics Inc. is seen as a Strong Buy due to explosive revenue growth, asset-light bala...
Elastic N.V. (ESTC) is expected to report $-0.34 for Q1 2025 Affimed N.V. (AFMD) is expected to report $-1 for Q2 2024 Cool Company Ltd. (CLCO) is expected to report $0.35 for Q2 2024 Delta Apparel Inc. (DLAPQ) is expected to report for Q3 2024 A-Mark Precious Metals Inc. (AMRK) i...
News, Short Squeeze, Breakout and More Instantly...
Aldeyra Therapeutics Inc. Company Name:
ALDX Stock Symbol:
NASDAQ Market:
Aldeyra Therapeutics Inc. Website:
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the resubmission of a New Drug Application (NDA) to the U.S. Food and Drug Administra...
Aldeyra Therapeutics Inc. (ALDX) is expected to report $-0.21 for Q2 2024 Cano Health Inc. Class A (CANOQ) is expected to report for Q2 2024 Aytu BioPharma Inc. (AYTU) is expected to report for quarter end 2024-06-30 BlackBerry Limited (BB) is expected to report $-0.04 for Q2 2025 ...
Aldeyra Therapeutics Inc. (ALDX) is expected to report $-0.21 for Q2 2024 FactSet Research Systems Inc. (FDS) is expected to report $3.6 for Q4 2024 China CITIC Bank Corp. Ltd. ADR (CHCJY) is expected to report for Q2 2024 Comera Life Sciences Holdings Inc. (CMRA) is expected to repor...